Tango Therapeutics TNGX Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Tango Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tango Therapeutics's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tango Therapeutics's total liabilities & equity?
- Tango Therapeutics (TNGX) reported total liabilities & equity of $435.79M in Q1 2026.
- How has Tango Therapeutics's total liabilities & equity changed year-over-year?
- Tango Therapeutics's total liabilities & equity increased by 58.9% year-over-year, from $274.31M to $435.79M.
- What is the long-term trend for Tango Therapeutics's total liabilities & equity?
- Over 5 years (2020 to 2025), Tango Therapeutics's total liabilities & equity has grown at a 14.0% compound annual growth rate (CAGR), from $207.25M to $398.69M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.